Avricore Health (TSX.V: AVCR) (OTC: AVCRF)
, a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward, has signed a partnership agreement with Ellerca Health Corp. The partnership is designed to leverage the two companies’ respective technologies and services in order to provide the most compelling diabetes screening and management solutions available for community pharmacy. Avricore’s focus is to make actionable health information more available by creating the largest rapid-testing network in pharmacy through its proprietary HealthTab(TM), a turnkey point-of-care testing solution that enables pharmacies to operate as diagnostic hubs, or community diagnostic centers, that connects them on a single, cloud-based platform. Ellerca improves patient care by offering leading technologies and innovation, including its exclusive 360Care(TM) app. Combining HealthTab’s unique diagnostics and data-management systems with the ongoing coaching and support of 360Care will allow the partnership to deliver enhanced patient services in the community pharmacy space. “We believe strongly that cooperation can enhance what we do, and that of those we work with,” said Avricore Health CEO Hector Bremner in the press release. “We’ve already identified several projects where HealthTab and 360Care can work together to support patient needs in pharmacy, and we look forward to continuing to work towards collaborating on these efforts.”
To view the full press release, visit https://ibn.fm/aUm13
About Avricore Health Inc.
Avricore Health is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab, a wholly owned subsidiary, the company’s mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies. Driving 360Care is the core philosophy that people with chronic health needs, when provided with true care and companionship, quickly make the incremental behavioral changes needed to stop the progression of their conditions. For more information about the company, please visit www.AvricoreHealth.com
NOTE TO INVESTORS:
The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
InvestorWire is part of the InvestorBrandNetwork.